FOLH1 and cancer: Additionally, post hoc analyses may be inherently susceptible to bias, and the results here should be confirmed by well‐designed prospective studies that consider use of prostate‐specific membrane antigen positron emission tomography, or PSMA PET, for cancer staging and earlier use of intensified treatments.